Prosthetic Joint Infection Market is Estimated to Witness High Growth Owing to Advancements in Anti-Microbial Coatings

Prosthetic joint infection refers to infections that occur in the tissues and bones surrounding artificial hip, knee, or shoulder joints that have been implanted through surgery. These infections are challenging to manage as they usually require long-term antibiotic therapy and sometimes need surgical intervention like irrigation and debridement, implant removal, or even amputation in severe cases. The growing number of total joint arthroplasties performed globally has led to a proportional rise in prosthetic joint infections. Advancements in anti-microbial coatings are helping reduce the risk of such infections post-surgery. Coatings that release antibiotics, antiseptics, or agents that prevent bacterial adhesion and biofilm formation are being developed and tested. This is expected to boost the adoption of coated implants and drive the growth of the prosthetic joint infection market.

The prosthetic joint infection market is estimated to be valued at USD 64.2 Mn in 2024 and is expected to reach USD 91.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

Key players

Key players operating in the Prosthetic Joint Infection market are Zimmer Biomet, Smith & Nephew, DePuy Synthes (Johnson & Johnson), Stryker, 3M Healthcare.

Increasing joint replacement surgeries worldwide along with the use of anti-microbial coatings and awareness regarding post-surgical infections present a large opportunity in the market.

Technological Prosthetic Joint Infection Market  advancements related to anti-microbial coatings that prevent bacterial adhesion and biofilm formation on implants are reducing infection risks and expected to drive the market growth over the forecast period.

Market drivers

The growing geriatric population suffering from osteoporosis and osteoarthritis is one of the major drivers of the prosthetic joint infection market. Age is the most important risk factor for joint replacements and thus infections. Moreover, the risk of infection is highest in the early post-operative period, hence long-term preventive measures are being increasingly adopted.

Current Challenges in Prosthetic Joint Infection Market:

Prosthetic joint infections pose significant challenges for patients as well as healthcare systems. The treatment of prosthetic joint infections is a lengthy and complex process that often involves multiple revision surgeries. Antibiotic resistance is also emerging as a major challenge with some bacteria forming biofilms that are highly resistant to antibiotic therapy. Delays in diagnosis can further complicate treatment and reduce chances of a successful outcome. Rising number of joint replacement surgeries have led to a corresponding rise in the number of prosthetic joint infections. This has placed immense pressure on limited healthcare resources.

SWOT Analysis

Strength: Strong product portfolio with differentiated solutions for treatment and prevention of infections. Extensive R&D focusing on development of novel anti-biofilm technologies.

Weakness: High costs associated with treatment that involves multiple revision surgeries and prolonged antibiotic therapy courses. Risk of antibiotic resistance reducing efficacy of existing treatment protocols.

Opportunity: Growth in orthopedic device market in emerging economies. Increased focus on preventive measures and novel drug delivery solutions to tackle antibiotic resistance.

Threats: Price controls and regulatory changes affecting reimbursement policies. Entry of local players offering low-cost generic solutions.

Geographical Regions

North America currently dominates the prosthetic joint infection market in terms of value owing to higher adoption of advanced treatment options and joint replacements in the region. The United States represents the single largest market globally.

The Asia Pacific region is poised to witness the fastest growth over the forecast period from 2024 to 2031. Factors such as rising healthcare expenditure, growing medical tourism industry and an increasing elderly patient population undergoing joint replacements will fuel market expansion. Countries like China, India and South Korea are emerging as lucrative markets.

Get this Report in Japanese Language: 原発性毛様体ジスキネジア市場

Get this Report in Korean Language:  원발성 섬모 운동이상증 시장

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh 590844163)